Beijing Peking University WBL Biotech Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Beijing Peking University WBL Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia (NCT01327014) | Beijing Peking University WBL Biotech Co., Ltd. | 2011-04-01 |
Track Beijing Peking University WBL Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.